CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for therapeutic applications

Posted on
cj-1:-an-optimized-mrna-platform-with-enhanced-protein-expression-and-minimal-immunogenicity-for-therapeutic-applications
CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for therapeutic applications

  • Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Three decades of messenger RNA vaccine development. Nano Today. 2019;28:100766. https://doi.org/10.1016/j.nantod.2019.100766.

    Article  CAS  Google Scholar 

  • Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20:817–38. https://doi.org/10.1038/s41573-021-00283-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Szabó GT, Mahiny AJ, Vlatkovic I. COVID-19 mRNA vaccines: platforms and current developments. Mol Ther. 2022;30:1850–68. https://doi.org/10.1016/j.ymthe.2022.02.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jahanafrooz Z, Baradaran B, Mosafer J, Hashemzaei M, Rezaei T, Mokhtarzadeh A, et al. Comparison of DNA and mRNA vaccines against cancer. Drug Discov Today. 2020;25:552–60. https://doi.org/10.1016/j.drudis.2019.12.003.

    Article  PubMed  Google Scholar 

  • Kong B, Kim Y, Kim EH, Suk JS, Yang Y. mRNA: a promising platform for cancer immunotherapy. Adv Drug Deliv Rev. 2023;199:114993. https://doi.org/10.1016/j.addr.2023.114993.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haghmorad D, Eslami M, Orooji N, Halabitska I, Kamyshna I, Kamyshnyi O, et al. mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy. Front Bioeng Biotechnol. 2025;13:1547025. https://doi.org/10.3389/fbioe.2025.1547025.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zeng C, Zhang C, Walker PG, Dong Y. Formulation and delivery technologies for mRNA vaccines. In: Yu D, Petsch B, editors. mRNA vaccines. Cham: Springer International Publishing; 2022. p. 71–110.

  • Yu M-Z, Wang N-N, Zhu J-Q, Lin Y-X. The clinical progress and challenges of mRNA vaccines. WIREs Nanomed Nanobiotechnology. 2023;15:e1894. https://doi.org/10.1002/wnan.1894.

    Article  CAS  Google Scholar 

  • Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci Transl Med. 2022;14:eabn8057. https://doi.org/10.1126/scitranslmed.abn8057.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N Engl J Med. 2021;385:e84. https://doi.org/10.1056/NEJMoa2114583.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Notarte KI, Guerrero-Arguero I, Velasco JV, Ver AT, Santos de Oliveira MH, Catahay JA, et al. Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: a systematic review. J Med Virol. 2022;94:2939–61. https://doi.org/10.1002/jmv.27688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McMenamin ME, Nealon J, Lin Y, Wong JY, Cheung JK, Lau EHY, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022;22:1435–43. https://doi.org/10.1016/S1473-3099(22)00345-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • SeyedAlinaghi S, Dashti M, Afzalian A, Siami H, Ghasemzadeh A, Varshochi S, et al. The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: a systematic review. Prev Med Rep. 2024;44:102778. https://doi.org/10.1016/j.pmedr.2024.102778.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618:144–50. https://doi.org/10.1038/s41586-023-06063-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. Lancet. 2024;403:632–44. https://doi.org/10.1016/S0140-6736(23)02268-7.

    Article  CAS  PubMed  Google Scholar 

  • Rohner E, Yang R, Foo KS, Goedel A, Chien KR. Unlocking the promise of mRNA therapeutics. Nat Biotechnol. 2022;40:1586–600. https://doi.org/10.1038/s41587-022-01491-z.

    Article  CAS  PubMed  Google Scholar 

  • Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther. 2022;7:166 https://doi.org/10.1038/s41392-022-01007-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao X, Zhong Y, Wang X, Shen J, An W. Advances in circular RNA and its applications. Int J Med Sci. 2022;19:975–85. https://doi.org/10.7150/ijms.71840.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol Ther. 2019;27:710–28. https://doi.org/10.1016/j.ymthe.2019.02.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 2010;38:5884–92. https://doi.org/10.1093/nar/gkq347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henderson JM, Ujita A, Hill E, Yousif-Rosales S, Smith C, Ko N, et al. Cap 1 messenger RNA synthesis with co-transcriptional CleanCap® analog by in vitro transcription. Curr Protoc. 2021;1:e39. https://doi.org/10.1002/cpz1.39.

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023;621:396–403. https://doi.org/10.1038/s41586-023-06127-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics—developing a new class of drugs. Nat Rev Drug Discov. 2014;13:759–80. https://doi.org/10.1038/nrd4278.

    Article  CAS  PubMed  Google Scholar 

  • Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, Kranz LM, Fesser S, et al. Improving mRNA-based therapeutic gene delivery by expression-augmenting 3′ UTRs identified by cellular library screening. Mol Ther. 2019;27:824–36. https://doi.org/10.1016/j.ymthe.2018.12.011.

    Article  CAS  PubMed  Google Scholar 

  • Jin L, Zhou Y, Zhang S, Chen S-J. mRNA vaccine sequence and structure design and optimization: advances and challenges. J Biol Chem. 2025;301:108015. https://doi.org/10.1016/j.jbc.2024.108015.

    Article  CAS  PubMed  Google Scholar 

  • Kim Y-A, Mousavi K, Yazdi A, Zwierzyna M, Cardinali M, Fox D, et al. Computational design of mRNA vaccines. Vaccine. 2024;42:1831–40. https://doi.org/10.1016/j.vaccine.2023.07.024.

    Article  CAS  PubMed  Google Scholar 

  • Cao J, Novoa EM, Zhang Z, Chen WCW, Liu D, Choi GCG, et al. High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies. Nat Commun. 2021;12:4138. https://doi.org/10.1038/s41467-021-24436-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xia X. Detailed dissection and critical evaluation of the Pfizer/BioNTech and moderna mRNA Vaccines. Vaccines. 2021;9:734.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Granados-Riveron JT, Aquino-Jarquin G. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomed Pharmacother. 2021;142:111953. https://doi.org/10.1016/j.biopha.2021.111953.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krawczyk PS, Mazur M, Orzeł W, Gewartowska O, Jeleń S, Antczak W, et al. Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines. Nature. 2025;641:984–92. https://doi.org/10.1038/s41586-025-08842-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Packer M, Gyawali D, Yerabolu R, Schariter J, White P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat Commun. 2021;12:6777. https://doi.org/10.1038/s41467-021-26926-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schober GB, Story S, Arya DP. A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient. Sci Rep. 2024;14:2403. https://doi.org/10.1038/s41598-024-52685-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • England CG, Ehlerding EB, Cai W. NanoLuc: a small luciferase is brightening up the field of bioluminescence. Bioconjugate Chem. 2016;27:1175–87. https://doi.org/10.1021/acs.bioconjchem.6b00112.

    Article  CAS  Google Scholar 

  • Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science. 1986;234:364–8.

    Article  CAS  PubMed  Google Scholar 

  • Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108:4009–17. https://doi.org/10.1182/blood-2006-04-015024.

    Article  CAS  PubMed  Google Scholar 

  • García-Marquina G, Zhang A, Sproviero M, Fang Y, Gardner AF, Robb GB, et al. Streamlined DNA template preparation and co-transcriptional 5′ capped RNA synthesis enabled by solid-phase catalysis. bioRxiv. 2023:2023 https://doi.org/10.1101/2023.10.28.564520.

  • Chen T-H, Potapov V, Dai N, Ong JL, Roy B. N1-methyl-pseudouridine is incorporated with higher fidelity than pseudouridine in synthetic RNAs. Sci Rep. 2022;12:13017. https://doi.org/10.1038/s41598-022-17249-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holcik M, Liebhaber SA. Four highly stable eukaryotic mRNAs assemble 3′ untranslated region RNA–protein complexes sharing cis and trans components. Proc Natl Acad Sci. 1997;94:2410–4. https://doi.org/10.1073/pnas.94.6.2410.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Z, Kiledjian M. The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity. Mol Cell Biol. 2000;20:6334–41. https://doi.org/10.1128/mcb.20.17.6334-6341.2000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets: regulatory role of a 3′-untranslated region pyrimidine-rich sequence*. J Biol Chem. 2002;277:1099–106. https://doi.org/10.1074/jbc.M108340200.

    Article  CAS  PubMed  Google Scholar 

  • Conrad NK, Steitz JA. A Kaposi’s sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J. 2005;24:1831–41. https://doi.org/10.1038/sj.emboj.7600662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paek KY, Hong KY, Ryu I, Park SM, Keum SJ, Kwon OS, et al. Translation initiation mediated by RNA looping. Proc Natl Acad Sci. 2015;112:1041–6. https://doi.org/10.1073/pnas.1416883112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Passmore LA, Coller J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat Rev Mol Cell Biol. 2022;23:93–106. https://doi.org/10.1038/s41580-021-00417-y.

    Article  CAS  PubMed  Google Scholar 

  • Lim J, Kim D, Lee Y-s, Ha M, Lee M, Yeo J, et al. Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation. Science. 2018;361:701–4. https://doi.org/10.1126/science.aam5794.

    Article  CAS  PubMed  Google Scholar 

  • Owens GC, Chappell SA, Mauro VP, Edelman GM. Identification of two short internal ribosome entry sites selected from libraries of random oligonucleotides. Proc Natl Acad Sci. 2001;98:1471–6. https://doi.org/10.1073/pnas.98.4.1471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Trainor BM, Ghosh A, Pestov DG, Hellen CUT, Shcherbik N. A translation enhancer element from black beetle virus engages yeast eIF4G1 to drive cap-independent translation initiation. Sci Rep. 2021;11:2461. https://doi.org/10.1038/s41598-021-82025-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chulakasian S, Chang T-J, Tsai C-H, Wong M-L, Hsu W-L. Translational enhancing activity in 5′ UTR of peste des petits ruminants virus fusion gene. FEBS J. 2013;280:1237–48. https://doi.org/10.1111/febs.12115.

    Article  CAS  PubMed  Google Scholar 

  • Song Z, Jin L, Jiao L, Yu R, Liu H, Zhang S, et al. ALC-0315 lipid-based mRNA LNP induces stronger cellular immune responses postvaccination. Mol Pharm. 2025;22:859–70. https://doi.org/10.1021/acs.molpharmaceut.4c00995.

    Article  CAS  PubMed  Google Scholar 

  • Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control. Release. 2015;217:345–51. https://doi.org/10.1016/j.jconrel.2015.08.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Karikó K, Muramatsu H, Keller JM, Weissman D. Increased erythropoiesis in mice injected with submicrogram quantities of Pseudouridine-containing mRNA encoding erythropoietin. Mol Ther. 2012;20:948–53. https://doi.org/10.1038/mt.2012.7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He Z, Song D, van Zalen S, Russell JE. Structural determinants of human ζ-globin mRNA stability. J Hematol Oncol. 2014;7:35 https://doi.org/10.1186/1756-8722-7-35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li CY, Liang Z, Hu Y, Zhang H, Setiasabda KD, Li J, et al. Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo. Mol Ther Nucleic Acids. 2022;30:300–10. https://doi.org/10.1016/j.omtn.2022.10.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mino T, Takeuchi O. Post-transcriptional regulation of immune responses by RNA binding proteins. Proc Jpn Acad Ser B Phys Biol Sci. 2018;94:248–58. https://doi.org/10.2183/pjab.94.017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wuebben C, Bartok E, Hartmann G. Innate sensing of mRNA vaccines. Curr Opin Immunol. 2022;79:102249. https://doi.org/10.1016/j.coi.2022.102249.

    Article  CAS  PubMed  Google Scholar 

    • Related Posts